How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Hiring in the age of artificial intelligence is becoming increasingly difficult, with one Bengaluru founder saying a flood of low-effort, AI-generated applications is making it harder to spot genuine ...

In 1963, Pete Dye and his wife, Alice, toured the British Isles and studied the architecture of the region's great courses. The trip would have a profound influence on their philosophies around golf ...

Despite being one of the smaller states in the country, South Carolina has plenty of distinct golf destinations: Myrtle Beach, Kiawah Island and Charleston are all worth their own trips. And then ...

The IAEA offers a wide spectrum of learning and training activities, as well as educational resources and capacity-building programmes. These include face-to-face training courses and workshops, ...

That post quickly picked up traction, with many opining about the usage of AI in resumes and job interviews.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...